Immatics Stock Today


USD 8.76  0.20  2.34%   

Market Performance
3 of 100
Odds Of Distress
Less than 28
Immatics is trading at 8.76 as of the 29th of June 2022; that is 2.34 percent increase since the beginning of the trading day. The stock's open price was 8.56. Immatics has about a 28 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Immatics NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of March 2022 and ending today, the 29th of June 2022. Please note, there could be an existing legal relationship between Immatics NV (IMTX) and ARYA Sciences Acquis (ARYA). Click here to learn more.
Fiscal Year End
IPO Date
2nd of July 2020
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. The company has 62.93 M outstanding shares of which 2.56 M shares are currently shorted by private and institutional investors with about 14.41 trading days to cover. More on Immatics NV

Moving together with Immatics

0.71BCTXBriaCell Therapeutics Financial Report 5th of July 2022 PairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Immatics Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Immatics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Immatics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Immatics NV has very high historical volatility over the last 90 days
Immatics NV has a poor financial position based on the latest SEC disclosures
About 36.0% of the company shares are held by company insiders
Related EntityARYA (ARYA Sciences Acquisition)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Immatics report their recommendations after researching Immatics' financial statements, talking to executives and customers, or listening in on Immatics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Immatics NV. The Immatics consensus assessment is calculated by taking the average forecast from all of the analysts covering Immatics.
Strong Buy4 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Immatics NV based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Immatics NV financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 4 - PoorDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares58.7 M62.9 M
Significantly Down
Slightly volatile
Weighted Average Shares Diluted58.7 M62.9 M
Significantly Down
Slightly volatile
Net Cash Flow from Operations(83.9 M)(81.8 M)
Fairly Down
Slightly volatile
Total Assets182.4 M174.6 M
Sufficiently Up
Slightly volatile
Total Liabilities160.8 M150.6 M
Notably Up
Slightly volatile
Current Assets162.7 M152.2 M
Notably Up
Slightly volatile
Current Liabilities89 M95.1 M
Notably Down
Slightly volatile
Total Debt32.2 M37.7 M
Fairly Down
Slightly volatile
Gross Margin0.890.9
Fairly Down
Slightly volatile
Asset Turnover0.180.168
Notably Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Immatics' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Immatics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Immatics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Immatics' financial leverage. It provides some insight into what part of Immatics' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Immatics' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Immatics deploys its capital and how much of that capital is borrowed.
Immatics cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 9.26 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Immatics NV has a current ratio of 2.77, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Immatics until it has trouble settling it off, either with new capital or with free cash flow. So, Immatics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Immatics NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Immatics to invest in growth at high rates of return. When we think about Immatics' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(83.94 Million)Share
Immatics NV (IMTX) is traded on NASDAQ Exchange in USA. It is located in Paul-Ehrlich-Strasse 15 and employs 373 people. Immatics is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 556.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immatics's market, we take the total number of its shares issued and multiply it by Immatics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Immatics NV conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 62.93 M outstanding shares of which 2.56 M shares are currently shorted by private and institutional investors with about 14.41 trading days to cover. Immatics NV currently holds about 252.74 M in cash with 43.98 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.02.
Check Immatics Probability Of Bankruptcy
Immatics NV has a total of sixty-two million nine hundred thirty thousand outstanding shares. Immatics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Immatics Ownership Details

Immatics Stock Price Odds Analysis

What are Immatics' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Immatics jumping above the current price in 90 days from now is about 12.96%. The Immatics NV probability density function shows the probability of Immatics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3109. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immatics will likely underperform. Additionally, the company has an alpha of 0.4902, implying that it can generate a 0.49 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 8.76HorizonTargetOdds Above 8.76
86.96%90 days
Based on a normal probability distribution, the odds of Immatics to move above the current price in 90 days from now is about 12.96 (This Immatics NV probability density function shows the probability of Immatics Stock to fall within a particular range of prices over 90 days) .

Immatics Historical Income Statement

Immatics NV Income Statement is one of the three primary financial statements used for reporting Immatics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Immatics NV revenue and expense. Immatics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Immatics Interest Expense is fairly stable at the moment as compared to the past year. Immatics reported Interest Expense of 1.73 Million in 2021. Net Income to Non Controlling Interests is likely to rise to about 598.4 K in 2022, whereas Consolidated Income is likely to drop (100.7 M) in 2022. View More Fundamentals

Immatics Stock Against Markets

Picking the right benchmark for Immatics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Immatics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Immatics is critical whether you are bullish or bearish towards Immatics NV at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immatics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Managers Now


Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Investing Immatics NV

You need to understand the risk of investing before taking a position in Immatics. The danger of trading Immatics NV is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Immatics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Immatics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Immatics NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Risk vs Return Analysis. Note that the Immatics NV information on this page should be used as a complementary analysis to other Immatics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Immatics Stock analysis

When running Immatics NV price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
556.9 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immatics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.